The Icelandic Medicines Agency has revoked the Z-classified status of medicinal products, which are exclusively used in hospitals and healthcare institution and will continue to be S-classified as announced on the IMA website earlier this month. Medicines which are exclusively used in hospitals and healthcare institutions will as of May 1st only be S-classified.
These amendments will be published in the Medicinal Product Information database in the coming days and the price list on the Icelandic Medicine Pricing and Reimbursement Committee. These changes do not affect reimbursement.